 |
 |

CDC Recommendations for Opt-Out HIV Testing—Reply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In Reply: Dr Holtgrave makes some good suggestions for a comprehensive list of metrics to obtain in the context of HIV testing, prevention, and care initiatives. Some of this work is under way. The CDC surveillance system produces estimates of the number of persons living with HIV in the United States, the proportion aware of their infection, and HIV incidence.1-2 The survival benefits of HIV treatment are well established.3 Cost-effectiveness of expanded testing has been assessed by the 3 studies cited in the Special Communication. The newly established North American HIV Database, which is part of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) project, will permit analysis of extensive longitudinally collected data from about 75 000 patients, but this will be largely limited to clinical and laboratory data.4
We are not aware of plans for systematic collection of nationally representative data on the number of people who . . . [Full Text of this Article]
John G. Bartlett, MD
jb@jhmi.edu Department of Medicine Johns Hopkins University School of Medicine Baltimore, Maryland
Kenneth Hugh Mayer, MD
Department of Medicine Brown University School of Medicine Providence, Rhode Island
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Opt-Out Testing for Human Immunodeficiency Virus in the United States: Progress and Challenges
John G. Bartlett, Bernard M. Branson, Kevin Fenton, Benjamin C. Hauschild, Veronica Miller, and Kenneth H. Mayer
JAMA. 2008;300(8):945-951.
ABSTRACT
| FULL TEXT
RELATED LETTERS
CDC Recommendations for Opt-Out HIV Testing
David R. Holtgrave
JAMA. 2009;301(3):274.
EXTRACT
| FULL TEXT
CDC Recommendations for Opt-Out HIV Testing
Lawrence Corey
JAMA. 2009;301(3):274-275.
EXTRACT
| FULL TEXT
|